Third Point 13F holdings, Q2 2002
Holdings as of June 30, 2002 · filings on SEC EDGAR · latest filing →
Third Point disclosed 25 US equity positions worth $197.5m in its Q2 2002 13F filing. The largest position was POTLATCH CORP at 15.0% of the reported book, followed by PENN VIRGINIA CORP and NTL COMM CORP 6 3/4% 05/15/08. Against the Q1 2002 filing, it opened 7 new positions, added to 6 and reduced 4 among the top 25 holdings.
What did Third Point own in Q2 2002? Top 25 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2002 |
|---|---|---|---|---|---|---|---|
| 1 | POTLATCH CORP | 15.0% | $29.6m | 868,900 | 32% | added | |
| 2 | PENN VIRGINIA CORP | 11.8% | $23.4m | 600,000 | 20% | added | |
| 3 | NTL COMM CORP 6 3/4% 05/15/08 | 10.7% | $21.1m | 64,088,000 | – | new | |
| 4 | SAXON CAPITAL INC | 8.7% | $17.2m | 1,060,000 | 6% | added | |
| 5 | VISTEON CORP | 8.4% | $16.6m | 1,170,000 | 0% | held | |
| 6 | FBR ASSET INVESTMENT CORP | 6.8% | $13.3m | 400,000 | 300% | added | |
| 7 | KINDRED HEALTHCARE INC | 4.2% | $8.2m | 185,000 | 0% | held | |
| 8 | PCG P G & E CORPORATION | Utilities | 4.0% | $7.8m | 438,000 | 5% | added |
| 9 | FIDELITY NATL STK | 3.4% | $6.7m | 210,657 | 248% | added | |
| 10 | JM SMUCKER CO/THE | 3.2% | $6.3m | 183,200 | – | new | |
| 11 | GENESIS HEALTH VENTURES | 3.1% | $6.0m | 300,000 | 0% | held | |
| 12 | AMERICAN PHYSICIANS CAP | 2.7% | $5.4m | 293,800 | 0% | held | |
| 13 | LUFKIN INDUSTRIES | 2.7% | $5.4m | 186,500 | – | new | |
| 14 | BARD (C.R.) INC | 2.6% | $5.1m | 90,900 | -63% | reduced | |
| 15 | CERES GROUP INC | 2.0% | $3.9m | 1,000,000 | 0% | held | |
| 16 | ADVANTA CORP | 2.0% | $3.9m | 355,000 | -10% | reduced | |
| 17 | AGERE SYSTEMS INC- A | 1.8% | $3.5m | 2,500,000 | – | new | |
| 18 | TRIZEC HAHN CORP SUB VTG | 1.6% | $3.1m | 182,215 | -74% | reduced | |
| 19 | BIOTRANSPLANT INC | 1.4% | $2.8m | 1,219,998 | – | new | |
| 20 | BINDVIEW DEVELOPMENT CORP | 1.4% | $2.7m | 2,590,300 | 0% | held | |
| 21 | LNC LINCOLN NATIONAL CORP | Financial Services | 1.1% | $2.1m | 50,000 | – | new |
| 22 | CRAY INC | 0.6% | $1.1m | 252,600 | 0% | held | |
| 23 | ENDO PHARMACEUT HLDGS IN | 0.6% | $1.1m | 160,900 | 0% | held | |
| 24 | AMBASSADORS GROUP INC | 0.5% | $1.0m | 70,400 | -15% | reduced | |
| 25 | DMC STRATEX NETWORKS | 0.0% | $97.0k | 48,080 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.